PRISM Emerging Gene Therapy

The PRISM Emerging Gene Therapy Index tracks small/micro-cap stocks which are developing or marketing treatments that are gene-based or otherwise target genetic material. Please note the default display sorts the companies by percent daily change. Additional sorting options allow soryting by name, volume, and percent change since index inception date.

PRISM Emerging Gene Therapy IndexInception Date of 1/2/2020 at $100.00% Change (Daily)Current Index Value% Change (Inception)
1.3%$115.6015.6%
Index ComponentsTickerCurrent Price% Daily ChangeVolume (1,000s)Average Volume (1,000s)Market Cap (Millions)1/2/2020 Price% Change Since Inception 1/2/2020
Editas Medicine, Inc.EDIT$30.59-2.39%1,094887$1,907$29.443.9%
Orchard Therapeutics plcORTX$5.073.68%728667$496$13.58-62.7%
Mustang Bio, Inc.MBIO$3.706.94%4,4681,642$243$4.10-9.8%
Atara Biotherapeutics, Inc.ATRA$23.19-0.34%648851$1,802$16.4141.3%
Bellicum Pharmaceuticals, Inc.BLCM$3.6915.67%617128$23$15.10-75.6%
Celyad SACYAD$9.830.92%226$134$11.25-12.6%
Intellia Therapeutics, Inc.NTLA$39.27-0.28%1,051987$2,320$14.58169.3%
Homology Medicines, Inc.FIXX$9.840.72%321428$445$20.53-52.1%
NeuBase Therapeutics, Inc.NBSE$7.67-0.39%136179$177$6.9011.2%
Stoke Therapeutics, Inc.STOK$52.091.8%157118$1,874$26.5496.3%
Precision BioSciences, Inc.DTIL$12.474.53%559686$654$13.14-5.1%
AVROBIO, Inc.AVRO$13.77-1.85%451248$571$20.61-33.2%
ZIOPHARM Oncology, Inc.ZIOP$2.80-3.78%1,5591,497$600$4.62-39.4%
Allogene Therapeutics, Inc.ALLO$31.05-1.49%457698$4,356$26.2218.4%
Translate Bio, Inc.TBIO$22.2214.83%2,228985$1,651$7.90181.3%
Solid Biosciences Inc.SLDB$3.314.09%2974,115$200$4.43-25.3%
Fortress Biotech, Inc.FBIO$2.75-0.72%7951,341$258$2.711.5%
MeiraGTx Holdings plcMGTX$14.121.58%192150$613$19.72-28.4%